An update on risk factors for relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
IF 3.4
3区 医学
Q3 IMMUNOLOGY
引用次数: 0
抗中性粒细胞胞浆抗体（ANCA）相关性血管炎复发风险因素的最新进展。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文
求助全文
来源期刊
CiteScore
8.40
自引率
2.20%
发文量
101
审稿时长
3-8 weeks
期刊介绍：
Clinical & Experimental Immunology (established in 1966) is an authoritative international journal publishing high-quality research studies in translational and clinical immunology that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice.
The journal is focused on translational and clinical immunology and is among the foremost journals in this field, attracting high-quality papers from across the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through scientific studies to the treatment, prevention or diagnosis of human disease. Clinical immunology has evolved as a field to encompass the application of state-of-the-art technologies such as next-generation sequencing, metagenomics and high-dimensional phenotyping to understand mechanisms that govern the outcomes of clinical trials.
文献相关原料
| 公司名称 | 产品信息 | 采购帮参考价格 |
|---|
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
